评估临床微生物学实践指南:美国微生物学会循证检验医学实践指南评估特设委员会
美国微生物学会专业实践委员会下设的循证检验医学实践指南委员会于2014年成立特设委员会,采用AGREE II工具评估已发布的实践指南。该评估有助于判断指南是否稳健、透明且清晰呈现实践推荐,并通过识别优缺点改进未来指南。本文简述特设委员会的建立及其对多项ASM最佳实践指南和一项非ASM指南的评审结果。
要点
- AGREE II工具用于标准化评估实践指南的稳健性、透明度和推荐清晰度。
- 特设委员会由ASM循证检验医学实践指南委员会于2014年成立。
- 评估结果可识别指南优缺点,促进未来指南改进。
核心结论
- 采用AGREE II评估有助于判断实践指南是否稳健、透明且清晰呈现推荐,并通过识别优缺点改进未来指南。
研究设计与样本
- 美国微生物学会循证检验医学实践指南委员会于2014年成立特设委员会,使用AGREE II工具评估已发布的实践指南。
主要发现
- 特设委员会评审了多项ASM最佳实践指南和一项来自急诊护士协会的非ASM实践指南。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
As part of the American Society for Microbiology (ASM) Evidence-Based Laboratory Medicine Practice Guidelines Committee of the Professional Practice Committee, an ad hoc committee was formed in 2014 to assess guidelines published by the committee using an assessment tool, Appraisal of Guidelines for Research Evaluation II (AGREE II). The AGREE II assessment helps reviewers determine whether published guidelines are robust, transparent, and clear in presenting practice recommendations in a standardized manner. Identifying strengths and weaknesses of practice guidelines by ad hoc assessments helps with improving future guidelines through the participation of key stakeholders. This minireview describes the development of the ad hoc committee and results from their review of several ASM best practices guidelines and a non-ASM practice guideline from the Emergency Nurses Association.
引用
- Nachamkin I, Kirn TJ, Westblade LF, et al. Assessing Clinical Microbiology Practice Guidelines: American Society for Microbiology Ad Hoc Committee on Evidence-Based Laboratory Medicine Practice Guidelines Assessment. J Clin Microbiol. 2017. PMID: 28835476. doi:10.1128/JCM.01124-17
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。